Clinical, Electrodiagnostic, and Genetic Features of Tangier Disease in an Adolescent Girl with Presentation of Peripheral Neuropathy

Abstract

Tangier disease (TD) is a rare, autosomal recessive inherited disorder caused by a mutation in the adenosine triphosphate-binding cassette transporter 1 (ABCA1) gene, which results in a decrease in plasma high-density lipoprotein (HDL) levels. Peripheral neuropathy can be seen in approximately 50% of patients with TD, which usually occurs after the age of 15 years, and is characterized by relapsing-remitting mono- or polyneuropathy or syringomyelia-like neuropathy. Herein, we report a 16-year-old female patient who was initially diagnosed with peripheral neuropathy at the age of 13 years. Whole exome sequencing was performed, and a nonsense mutation (p.Arg1817X) in ABCA1 was identified. The patient was investigated for systemic findings of TD after the genetic diagnosis was made, and low (< 5 mg/dL) levels of HDL cholesterol were detected by lipid electrophoresis. Other family members were reexamined after the diagnosis of the proband, and asymptomatic sister of the proband was diagnosed with TD. We would like to emphasize that TD should be considered in the differential diagnosis of pediatric patients presenting with peripheral neuropathy; furthermore detection of HDL levels by lipid electrophoresis is a simple but indicative diagnostic test.

Keywords

Tangier disease - neuropathy - whole exome sequencing - ABCA1

• References

• 1 Fredrickson DS. The inheritance of high density lipoprotein deficiency (Tangier disease). J Clin Invest 1964; 43: 228-236
• 2 Hoffman HN, Fredrickson DS. Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. Am J Med 1965; 39 (4) 582-593
• 3 Brooks-Wilson A, Marcil M, Clee SM , et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22 (4) 336-345
• 4 Lawn RM, Wade DP, Garvin MR , et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104 (8) R25-R31
• 5 Zyss J, Béhin A, Couvert P , et al. Clinical and electrophysiological characteristics of neuropathy associated with Tangier disease. J Neurol 2012; 259 (6) 1222-1226
• 6 Mishra-Gorur K, Çağlayan AO, Schaffer AE , et al. Mutations in KATNB1 cause complex cerebral malformations by disrupting asymmetrically dividing neural progenitors. Neuron 2014; 84 (6) 1226-1239
• 7 Puntoni M, Sbrana F, Bigazzi F, Sampietro T. Tangier disease: epidemiology, pathophysiology, and management. Am J Cardiovasc Drugs 2012; 12 (5) 303-311
• 8 Schmitz G, Grandl M. The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis. Arterioscler Thromb Vasc Biol 2009; 29 (11) 1718-1722
• 9 Fasano T, Zanoni P, Rabacchi C , et al. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. Mol Genet Metab 2012; 107 (3) 534-541
• 10 Meco JF, Pinto X, Quintana E, Fiol C, Castiñeiras MJ, Pujol R. Efficacy of hygienic and dietary therapy in coronary patients with isolated hypoalphalipoproteinemia [in Spanish]. Med Interna 1999; 16 (12) 620-625